Dong X, et al. – The researchers explored the expression and clinicopathological significance of neuropilin–2 (NRP2) in hepatocellular carcinoma (HCC) patients. They described that NRP2 expression was considered as an independent factor for the prediction of unfavorable prognosis in HCC patients. They suggested that NRP2 could serve as a biomarker of poor prognosis and a novel target in treating HCC tumors.